A new phase III trial for treatment of carcinoma of the cervix

International Journal of Hyperthermia

Volumn 18, Issue 1, 2002, Pages 31-32

  Prosnitz, L ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; EDITORIAL; HUMAN; HYPERTHERMIC THERAPY; OUTCOMES RESEARCH; PHASE 3 CLINICAL TRIAL; UTERINE CERVIX CARCINOMA;

CLINICAL TRIALS, PHASE III; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; UTERINE CERVICAL NEOPLASMS;

EID: 0036150248     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730110091928     Document Type: Editorial

References (6)

1. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Ducth Deep Hyperthermia Group
2. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
3. Cisplatin radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
4. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
5. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
6. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix